Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 4.01 -0.24 (5.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.25 | 52 Week High | $ | |||
| Open | $4.21 | 52 Week Low | $ | |||
| Day High | $4.21 | P/E | N/A | |||
| Day Low | $3.98 | EPS | $ | |||
| Volume | 553,563 | |||||

